Molecular Diagnostics Cancer Oncology - Global Market Size, Strategy and Forecasts - 2016 to 2019
Publication date: January 18,2016
Our facts. Your success.
“Next Generation Sequencing and new Molecular Diagnostics Tests drive market growth while lowering costs....."
“Bioinformatics creates new challenges.....”
Use independent research that makes you the expert. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it.
LEARN MORE. Request your Free Executive Summary with Key Market Trends and Competitive Insights
Just looking for Market Size Data? Order just the Table(s) for the country you need. If your country is not listed please enquire. We have data for most countries of the world and can help you work with it.
A market that just keeps on growing. Molecular Diagnostics is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report from Howe Sound Research. A range of dynamic trends are pushing market growth and company valuations. Trends like ......
- personalized medicine
- next generation sequencing
- emergence of new economies with large markets
- greater understanding of the role of genetic material in Disease and Health
Exciting technical developments especially in the area of pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.
The report data is designed to be used! The unit volumes of tests performed is presented. Use our pricing scenarios or use your own. Project your market share and your price to reliably generate revenue forecasts or understand your own current market share position. Detailed Market Forecasts provide Price, Volume and Revenue Forecasts individually broken out by year for Oncology Testing.
"Molecular Diagnostics - Global Market Size, Strategy and Forecasts - 2016 to 2019" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2015 United States Medicare Fee Payment Schedules to help understand test pricing in detail. See lists of all current FDA Approved Molecular Diagnostic Tests. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges. Questions? Email us at service at howesoundresearch.com. We would be glad to let you know if we can be of help.
“ This is an impressive piece of work.” Doug Buchanan, Managing Director and CEO BC Biomedical Laboratories Ltd.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasors of the report.
All report data is available in Excel format on request.
See the Sample Data Pages . Data summary pages are provided for the entire world and world regions permitting global and continental forecasting.
See the Table of Contents. Hundreds of pages of useful information, hard data and up to date market developments.
Make investment decisions and valuations with confidence using the latest data.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research.
He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
B.Sc. (Chemistry) University of BC
M.B.A. (Finance and Policy) University of BC
Market Research - Burke Institute
Finance for Senior Executives - Harvard Business School